Internal Medicine, Infectious Disease · Sarasota, FL
NPI
1609877190
Since 2005
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1231 N Tuttle Ave
Sarasota, FL, 34237
Phone (941) 366-0134
Groups this clinician bills Medicare through
Medicare paid, 2024
$18K
352 services
Medicare patients, 2024
79
Average age 66
Drug cost, 2024
$7.5M
6,352 prescriptions
Company payments, 2025
$270
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Tanya S Schreibman was code 99214 (office e&m - established), 154 times for 77 patients. In total Tanya S Schreibman billed 352 services in 14 codes, and Medicare paid $18K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-10-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 154 | 77 | $83.24 | $13K |
| 36415 Venipuncture Blood Collection | Office | 139 | 60 | $8.65 | $1,202 |
By year: 2022 $18K for 428 services; 2023 $21K for 407 services; 2024 $18K for 352 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 139 | 60 | $8.65 | $1,202 |
Medicare prescription drug claims, 2024
In 2024, the drug Tanya S Schreibman prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 616 prescriptions and refills. In total Tanya S Schreibman wrote 6,352 Medicare prescriptions that cost $7.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 616 | 616 | 64 | $2.4M |
| Rosuvastatin Calcium Generic | 368 | 456 | 42 | $2,006 |
| Amlodipine Besylate Generic | 338 | 357 | 32 | $548 |
| Dovato Dolutegravir Sodium/Lamivudine | 337 | 346 | 39 | $1.0M |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 210 | 226 | 19 | $767K |
| Tivicay Dolutegravir Sodium | 205 | 205 | 20 | $456K |
| Omeprazole Generic | 202 | 242 | 23 | $1,198 |
| Gabapentin Generic | 170 | 180 | 24 | $1,346 |
| Prezcobix Darunavir/Cobicistat | 164 | 164 | 16 | $401K |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 151 | 153 | 26 | $553K |
| Atorvastatin Calcium Generic | 146 | 164 | 15 | $303 |
| Testosterone Generic | 139 | 162 | 20 | $13K |
| Lisinopril Generic | 137 | 149 | 14 | $175 |
| Hydrochlorothiazide Generic | 130 | 148 | 16 | $133 |
| Odefsey Emtricitab/Rilpiviri/Tenof Ala | 126 | 134 | 13 | $464K |
Brand drugs: - claims; generic drugs: 3,841 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Tanya S Schreibman $270 ($270 in general payments such as food, travel and fees) from 6 companies. The largest payer was Gilead Sciences, Inc. with $128.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.